I want twice-yearly lenacapavir for PrEP. No daily pills, no bimonthly clinic visits, no kidney exposure at all. CAB-LA is good, but lenacapavir is the first option that feels like real liberation from the medical micromanagement of prevention. Two shots a year is the future.

Most people won’t reach overt kidney disease, but long-term TDF users carry years of silent renal stress. That’s the real scientific argument for injectable PrEP like CAB-LA: it avoids the kidney pathway entirely.

The small dip in bone density some users see isn’t the harm. It’s a signal of low-grade proximal tubule stress and mitochondrial strain that causes phosphate loss and hormonal shifts well before creatinine changes.

It’s not generic Truvada that’s the problem. Generic and brand are identical. The real issue is TDF itself and the quiet strain it puts on the kidneys, long before anything shows up on annual labs for creatine levels.

Much harder

🥵 what @toppedtoys.com plug is this?

this:

Come pound me into my massage table 😘

What dildo is that? Beautiful.